18F 2Fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) response to predict event-free survival (EFS) in intermediate risk (IR) or high risk (HR) rhabdomyosarcoma (RMS): A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (COG) Meeting Abstract


Authors: Harrison, D. J.; Parisi, M. T.; Shulkin, B. L.; Chi, Y. Y.; Anderson, J. R.; Mi, X.; Malempati, S.; Mascarenhas, L.; McCowage, G. B.; Weigel, B.; Wolden, S. L.; Yock, T. I.; Rodeberg, D. A.; Hayes-Jordan, A. A.; Teot, L. A.; Spunt, S. L.; Meyer, W. H.; Hawkins, D. S.
Abstract Title: 18F 2Fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) response to predict event-free survival (EFS) in intermediate risk (IR) or high risk (HR) rhabdomyosarcoma (RMS): A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (COG)
Meeting Title: 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 15 Suppl.
Meeting Dates: 2016 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-05-20
Start Page: 559s
Language: English
ACCESSION: WOS:000404712500343
DOI: 10.1200/JCO.2016.34.15_suppl.10549
PROVIDER: wos
Notes: Meeting Abstract: 10549 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Suzanne L Wolden
    560 Wolden